No Carolina / NY / Florida
Ph: 561.316.3330

Jim Pearson

The Journey to Establishing the World’s First Successful Surgical Treatment for Hemorrhagic Stroke | By Jim Pearson, President & CEO, NICO Corporation

Jim Pearson advises October 29th is World Stroke Day (WSD) — an important day for the global stroke community to take action, educate, and focus on prevention. It is also a chance to deeply reflect on how we can continue to serve people who will suffer strokes in the future. For us leaders in the life sciences, WSD is a powerful reminder to ask ourselves how we can continue to innovate in order to decrease the lives lost and improve both clinical and economic outcomes. Over the past decade, we have built a company and team at NICO Corporation dedicated to bringing forth new innovations and, more importantly, scientific evidence in the deadliest type of stroke — hemorrhagic stroke. Read to learn more.
- Advertisement -spot_img

Latest News

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.
- Advertisement -spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy